Summary: It is estimated that people traveling to Latin America have a 50 percent risk of developing diarrhea, most commonly caused by a certain bacteria. A pharmaceutical company is preparing for a clinical research study and participants will be compensated up to $900 while traveling abroad. This may cover the cost of a 2-week language immersion experience (excluding airfare).

New Vaccine Could Eradicate Symtoms of Traveler's Diarrhea

It is estimated that people traveling to Latin America have a 50 percent risk of developing diarrhea, most commonly caused by a certain bacteria.  A pharmaceutical company based in Gaithersburg, Maryland is preparing for a clinical research study of an investigational vaccine for traveler’s diarrhea. The study will evaluate the study vaccine to determine if it may prevent or lessen the symptoms of travelers' diarrhea from developing. The investigational vaccine is given via a patch on the skin that is worn for approximately six hours. Two patches are applied in the month prior to departure.
 
You must be in country for at least 7 days.  Participation in this study is entirely voluntary. Participants will be compensated up to $900.  In most cases, this would cover the cost of a 2-week language immersion experience (excluding airfare).  In essence, you can travel for free!  Currently, arrangements have been made so that travelers may participate in the study while in or near:

• Cuernavaca, Mexico
• Morelia, Mexico
• Puerto Vallarta, Mexico
• San Miguel de Allende, Mexico
• Antigua, Guatemala

Those interested in the research study can learn more from AmeriSpan Study Abroad by signing up to receive more information here: http://www.amerispan.com/research_study_form.asp.

Visit the Research Form to learn how you may earn $900 and participate in an AmeriSpan Study Abroad program. John Slocum is the president of AmeriSpan, a leader in immersion language programs and study abroad since 1993. 85 cities, 35 countries. 25,000 past participants. http://www.amerispan.com.